Cargando…

Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer

Thrombospondin-2 (THBS2) is a secreted protein overexpressed in numerous cancers and may function as a diagnostic tumor marker. The objective of the present study was to investigate the diagnostic performance of serum THBS2 in early stage non-small-cell lung cancer (NSCLC). Serum THBS2 and Cyfra21-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yi-ming, Yu, Dan-lu, Hou, Guo-xin, Jiang, Jia-lu, Zhou, Qiang, Xu, Xiao-fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658726/ https://www.ncbi.nlm.nih.gov/pubmed/31296790 http://dx.doi.org/10.1042/BSR20190476

Ejemplares similares

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
por: Zhang, Xintong, et al.
Publicado: (2022)

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
por: Fang, Rui, et al.
Publicado: (2018)

Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer
por: Li, Lanzhi, et al.
Publicado: (2021)

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
por: Li, Junfeng, et al.
Publicado: (2023)

Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics
por: Zhang, Bin, et al.
Publicado: (2013)

Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
por: Duan, Xiaotong, et al.
Publicado: (2021)

Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer
por: Sun, Mingzhong, et al.
Publicado: (2016)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer
por: Han, Hong-Yan, et al.
Publicado: (2021)

Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer
por: Li, Zengxun, et al.
Publicado: (2022)

Small non-coding RNA biomarkers in sputum for lung cancer diagnosis
por: Su, Yun, et al.
Publicado: (2016)

Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis
por: Liu, Xuefei, et al.
Publicado: (2022)

Thrombospondins and synaptogenesis★
por: Wang, Bin, et al.
Publicado: (2012)

Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder
por: Lim, So-Hee, et al.
Publicado: (2021)

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
por: Su, Feng, et al.
Publicado: (2007)

Decreased serum levels of thrombospondin‐1 in female depressed patients
por: Okada‐Tsuchioka, Mami, et al.
Publicado: (2019)

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)
por: Zhang, Kaijie, et al.
Publicado: (2020)

Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
por: Lu, Qiong, et al.
Publicado: (2021)

Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
por: Tao, Yao, et al.
Publicado: (2020)

MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2015)

Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease
por: Lin, Zhenzhen, et al.
Publicado: (2023)

Contribution of Thrombospondin-1 and -2 to Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome
por: Li, Qiang, et al.
Publicado: (2021)

Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression
por: Zhang, Jia-Jia, et al.
Publicado: (2021)

The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome
por: Jiang, Huali, et al.
Publicado: (2020)

Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
por: Zhang, Chuantao, et al.
Publicado: (2021)

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2016)

Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin
por: Lewiński, Andrzej, et al.
Publicado: (2013)

Clusterin as a serum biomarker candidate contributes to the lung fibroblasts activation in chronic obstructive pulmonary disease
por: Zhang, Qiang, et al.
Publicado: (2022)

Serum miR‐205‐5p level for non–small‐cell lung cancer diagnosis
por: Lu, Li‐Guo, et al.
Publicado: (2022)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers
por: Fang, Kai, et al.
Publicado: (2022)

Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer
por: Yang, Xia, et al.
Publicado: (2019)

Identifying candidate diagnostic markers for early stage of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Seven tumor‐associated autoantibodies as a serum biomarker for primary screening of early‐stage non‐small cell lung cancer
por: Chen, Ping, et al.
Publicado: (2021)

Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family
Publicado: (1993)

Modulation of the extracellular matrix patterning of thrombospondins by actin dynamics and thrombospondin oligomer state
por: Hellewell, Andrew L., et al.
Publicado: (2015)

Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
por: Xia, Xin, et al.
Publicado: (2016)

Publisher Correction: Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder
por: Lim, So-Hee, et al.
Publicado: (2021)

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer
por: Tian, Peng-Fei, et al.
Publicado: (2022)

Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma
por: Huang, Yajie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4aabd5kbf6p2rj2d905l6iqopc